Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Institut de Cancérologie de la Loire

Status: Completed

Conditions: Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT02025894

2010-01

2010-A01064-35 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

Enrollment: 3,032 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with a neoplastic solid tumour with an indication for insertion of a PCVC.

Exclusion criteria

• Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion,
• Therapeutic doses of anticoagulants required at inclusion,
• PCVC inserted by the femoral vein

Trial design

3,032 participants in 1 patient group

PCVCs

Description:

Cohort of cancer patients with indication PCVC under the usual practice